Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Targeting receptors to better treat AML

    Author:
    HT Staff
    Publish date: May 1, 2015

    Photo courtesy of UT Southwestern Medical Center Preclinical research suggests that certain receptors containing the immunoreceptor tyrosine-...

    • Read More

    News

    Enzyme could enable creation of universal blood type

    Author:
    HT Staff
    Publish date: April 30, 2015

    Photo by Elise Amendola Chemists have generated an enzyme that shows the potential for converting type A or B blood into a universal blood type...

    • Read More

    News

    Identifying artemisinin resistance not so straightforward

    Author:
    HT Staff
    Publish date: April 30, 2015

    Photo by Juan D. Alfonso The current method used to identify resistance to the antimalarial drug artemisinin is not entirely accurate, according...

    • Read More

    News

    Analysis helps quantify HU use in SCA

    Author:
    HT Staff
    Publish date: April 29, 2015

    Photo by Zak Hubbard Results of a retrospective study reinforce the idea that hydroxyurea (HU) is underused in US patients with sickle cell...

    • Read More

    News

    Team discovers mechanism behind malaria progression

    Author:
    HT Staff
    Publish date: April 29, 2015

    a red blood cell Photo courtesy of St.

    • Read More

    News

    Vena cava filter doesn’t reduce risk of recurrent PE

    Author:
    HT Staff
    Publish date: April 29, 2015

    Photo from Business Wire Retrievable inferior vena cava filters do not reduce the risk of recurrent pulmonary embolism (PE) or death in patients...

    • Read More

    News

    Study sheds new light on decitabine

    Author:
    HT Staff
    Publish date: April 28, 2015

    Image by Christoph Bock A new study helps explain how the anticancer drug decitabine reverses cell damage and has revealed a potential biomarker...

    • Read More

    News

    MM drug met accelerated approval requirements

    Author:
    HT Staff
    Publish date: April 28, 2015

    Photo courtesy of the CDC Celgene Corporation has fulfilled the requirements for accelerated approval of pomalidomide (Pomalyst) in the US, based...

    • Read More

    News

    HL survivors have long-term risk of cardiovascular disease

    Author:
    HT Staff
    Publish date: April 28, 2015

    Photo by Rhoda Baer Survivors of Hodgkin lymphoma (HL) have an increased risk of developing cardiovascular diseases throughout their lives,...

    • Read More

    News

    Drug can prevent bleeding in kids with hemophilia A

    Author:
    HT Staff
    Publish date: April 27, 2015

    Children who were previously receiving factor VIII prophylaxis saw their median annualized bleeding rate (ABR) decrease with rFVIIIFc, and close...

    • Read More

    News

    Chemotherapy drugs recalled in US

    Author:
    HT Staff
    Publish date: April 27, 2015

    Photo by Bill Branson The pharmaceutical company Mylan is conducting a US-wide recall of several injectable chemotherapy drugs. Testing of...

    • Read More

    News

    CDK inhibitor proves active against AML, ALL

    Author:
    HT Staff
    Publish date: April 26, 2015

    PHILADELPHIA—Preclinical research suggests a cyclin-dependent kinase (CDK) inhibitor is active against acute leukemias, particularly those with...

    • Read More

    News

    Malaria vaccine candidate proves somewhat effective

    Author:
    HT Staff
    Publish date: April 24, 2015

    Photo by Caitlin Kleiboer The malaria vaccine candidate RTS,S/AS01 is somewhat effective in young African children for up to 4 years after...

    • Read More

    News

    miR expression may predict long-term prognosis in DLBCL

    Author:
    HT Staff
    Publish date: April 24, 2015

    Photo courtesy of NIH MicroRNA (miR) expression may help us predict long-term prognosis in diffuse large B-cell lymphoma (DLBCL), according to a...

    • Read More

    News

    Meeting plasma transfusion guideline is feasible

    Author:
    HT Staff
    Publish date: April 24, 2015

    Photo by Cristina Granados High-volume trauma centers can provide consistent, rapid delivery of universal-donor plasma to massively hemorrhaging...

    • Read More

    Pages

    • « first
    • …
    • 180
    • 181
    • 182
    • 183
    • 184
    • 185
    • 186
    • 187
    • 188
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery